Ginkgo Bioworks Holdings Profit Margin 2020-2023 | DNA
Current and historical gross margin, operating margin and net profit margin for Ginkgo Bioworks Holdings (DNA) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Ginkgo Bioworks Holdings net profit margin as of March 31, 2023 is -440.87%.
| Ginkgo Bioworks Holdings Annual Profit Margins |
| Ginkgo Bioworks Holdings Quarterly Profit Margins |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$3.608B |
$0.478B |
|
Ginkgo Bioworks platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo Bioworks, formerly known as Soaring Eagle Acquisition Corp., is based in NEW YORK.
|
